BIOMARKER:

TP53 mutation + KRAS mutation

Entrez ID:

Related biomarkers:

‹

›

TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Non Small Cell Lung Cancer NSCLC	TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Non Small Cell Lung Cancer NSCLC	Immunotherapy Sensitive: B - Late Trials	Immunotherapy Sensitive: B - Late Trials
TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Lung Adenocarcinoma LUAD	TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Lung Adenocarcinoma LUAD	PD-L1 inhibitor Sensitive: C3 – Early Trials	PD-L1 inhibitor Sensitive: C3 – Early Trials
TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Lung Adenocarcinoma LUAD	TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Lung Adenocarcinoma LUAD	PD1 inhibitor Sensitive: C3 – Early Trials	PD1 inhibitor Sensitive: C3 – Early Trials
TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma	TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma	PD1 inhibitor Sensitive: C3 – Early Trials	PD1 inhibitor Sensitive: C3 – Early Trials
TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Colon Cancer Colon Cancer	TP53 mutation + KRAS mutation TP53 mutation + KRAS mutation	Colon Cancer Colon Cancer	LY 2603618 Sensitive: D – Preclinical	LY 2603618 Sensitive: D – Preclinical